Tenaya Therapeutics, Inc.
TNYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,275 | -$23,283 | -$26,864 | -$23,836 |
| Dep. & Amort. | $1,864 | $2,384 | $2,661 | $2,089 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,636 | $3,731 | $3,759 |
| Change in WC | -$921 | $1,007 | -$3,435 | -$1,036 |
| Other Non-Cash | $3,733 | $643 | $795 | $636 |
| Operating Cash Flow | -$15,599 | -$15,613 | -$23,112 | -$18,388 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$26 | -$142 | -$383 | -$204 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$2,011 |
| Inv. Sales/Matur. | $8,886 | $25,130 | $22,685 | $16,318 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $8,860 | $24,988 | $22,302 | $14,103 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $380 | -$476 | $50,259 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $377 |
| Financing Cash Flow | $380 | -$476 | $50,259 | $377 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,359 | $8,899 | $49,449 | -$3,908 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $62,671 | $54,191 | $4,742 | $8,650 |
| End Cash | $56,312 | $63,090 | $54,191 | $4,742 |
| Free Cash Flow | -$15,625 | -$15,755 | -$23,495 | -$18,592 |